Q2 2020 Alpine Immune Sciences Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and thank you for joining the Alpine Immune Sciences second-quarter 2020 financial results and corporate update conference call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. (Operator Instructions) As a reminder, this conference is being recorded today, Tuesday, August 11, 2020.
I would now like to introduce Laurence Watts, Investor Relations. Please, go ahead.
Thank you, Sydney. With me on today's call from Alpine Immune Sciences, are Executive Chairman and CEO, Dr. Mitchell Gold; President and Head of Research and Development, Dr. Stanford Peng; Chief Financial Officer, Paul Rickey; and Senior Vice President of Business Development and Corporate Strategy, Remy Durand.
[This afternoon] Alpine Immune Sciences issued a press release announcing the company's second-quarter 2020 financial results and corporate update. If you have not received this news release and would like to read it
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |